RxDoctor Payments DataLook up a doctor →

SUPPRELIN: payments to doctors

Payments that named SUPPRELIN as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$142K
Providers
496
Transactions
1,341
Average per transaction
$106

The per-transaction average — $106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 496 providers the average total is $287, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Endo Pharmaceuticals Inc.$124,30787.2%
Endo USA, Inc.$18,16912.8%
← All drugs & devices